Cargando…

Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis

BACKGROUND: The analysis of cerebrospinal fluid (CSF) is usually done under steady-state conditions, when proteins (e.g., immunoglobulins) reach diffusion equilibrium between blood and CSF. However, little data has been published on CSF analysis under non-steady-state conditions after therapeutic ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Benjamin, Hottenrott, Tilman, Leubner, Jonas, Dersch, Rick, Rauer, Sebastian, Stich, Oliver, Prüss, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676889/
https://www.ncbi.nlm.nih.gov/pubmed/26830688
http://dx.doi.org/10.1186/s12883-015-0515-x
_version_ 1782405250870673408
author Berger, Benjamin
Hottenrott, Tilman
Leubner, Jonas
Dersch, Rick
Rauer, Sebastian
Stich, Oliver
Prüss, Harald
author_facet Berger, Benjamin
Hottenrott, Tilman
Leubner, Jonas
Dersch, Rick
Rauer, Sebastian
Stich, Oliver
Prüss, Harald
author_sort Berger, Benjamin
collection PubMed
description BACKGROUND: The analysis of cerebrospinal fluid (CSF) is usually done under steady-state conditions, when proteins (e.g., immunoglobulins) reach diffusion equilibrium between blood and CSF. However, little data has been published on CSF analysis under non-steady-state conditions after therapeutic apheresis. By reducing serum proteins (e.g., immunoglobulins), while leaving CSF unchanged, therapeutic apheresis might cause spuriously altered intrathecal immunoglobulin fractions. METHODS: Based on the incidental finding of plasma exchange-induced increased intrathecal immunoglobulin fractions in a cohort of 12 unsystematically selected patients with various neurological disorders, we retrospectively investigated CSF results that had been raised during routine diagnostic work-up from 41 consecutive neurological patients (predominantly Guillain-Barré syndrome and autoimmune encephalitis) treated with plasmapheresis or immunoadsorption in a tertiary care university hospital in whom lumbar puncture (LP) was performed after a varying number of treatments of therapeutic apheresis. RESULTS: Only when LP was performed 1 day after therapeutic apheresis, spurious quantitative intrathecal immunoglobulin (Ig) synthesis of at least one subclass (IgG, IgA and/or IgM) was found in 68.4 % of the patients, irrespective of the number of treatments, in all age groups and independent of other previous immunotherapies (e.g., steroids). This phenomenon occurred only transiently and was almost always accompanied by an elevation of the IgG index. In one patient, an elevated IgG index was noticed even 2 days after plasmapheresis. Neither quantitative Ig synthesis, nor elevated IgG index was observed when the LP was performed three or more days after therapeutic apheresis. CONCLUSIONS: Spurious quantitative intrathecal Ig synthesis and increased IgG index are common findings shortly after plasmapheresis or immunoadsorption due to altered serum immunoglobulin levels. Knowledge of this phenomenon is needed for clinicians to prevent false interpretations leading to unnecessary diagnostic and therapeutic procedures. Misdiagnoses can be avoided by considering the characteristic CSF constellation including absence of oligoclonal bands and the close temporal relation to therapeutic apheresis.
format Online
Article
Text
id pubmed-4676889
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46768892015-12-13 Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis Berger, Benjamin Hottenrott, Tilman Leubner, Jonas Dersch, Rick Rauer, Sebastian Stich, Oliver Prüss, Harald BMC Neurol Research Article BACKGROUND: The analysis of cerebrospinal fluid (CSF) is usually done under steady-state conditions, when proteins (e.g., immunoglobulins) reach diffusion equilibrium between blood and CSF. However, little data has been published on CSF analysis under non-steady-state conditions after therapeutic apheresis. By reducing serum proteins (e.g., immunoglobulins), while leaving CSF unchanged, therapeutic apheresis might cause spuriously altered intrathecal immunoglobulin fractions. METHODS: Based on the incidental finding of plasma exchange-induced increased intrathecal immunoglobulin fractions in a cohort of 12 unsystematically selected patients with various neurological disorders, we retrospectively investigated CSF results that had been raised during routine diagnostic work-up from 41 consecutive neurological patients (predominantly Guillain-Barré syndrome and autoimmune encephalitis) treated with plasmapheresis or immunoadsorption in a tertiary care university hospital in whom lumbar puncture (LP) was performed after a varying number of treatments of therapeutic apheresis. RESULTS: Only when LP was performed 1 day after therapeutic apheresis, spurious quantitative intrathecal immunoglobulin (Ig) synthesis of at least one subclass (IgG, IgA and/or IgM) was found in 68.4 % of the patients, irrespective of the number of treatments, in all age groups and independent of other previous immunotherapies (e.g., steroids). This phenomenon occurred only transiently and was almost always accompanied by an elevation of the IgG index. In one patient, an elevated IgG index was noticed even 2 days after plasmapheresis. Neither quantitative Ig synthesis, nor elevated IgG index was observed when the LP was performed three or more days after therapeutic apheresis. CONCLUSIONS: Spurious quantitative intrathecal Ig synthesis and increased IgG index are common findings shortly after plasmapheresis or immunoadsorption due to altered serum immunoglobulin levels. Knowledge of this phenomenon is needed for clinicians to prevent false interpretations leading to unnecessary diagnostic and therapeutic procedures. Misdiagnoses can be avoided by considering the characteristic CSF constellation including absence of oligoclonal bands and the close temporal relation to therapeutic apheresis. BioMed Central 2015-12-11 /pmc/articles/PMC4676889/ /pubmed/26830688 http://dx.doi.org/10.1186/s12883-015-0515-x Text en © Berger et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Berger, Benjamin
Hottenrott, Tilman
Leubner, Jonas
Dersch, Rick
Rauer, Sebastian
Stich, Oliver
Prüss, Harald
Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
title Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
title_full Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
title_fullStr Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
title_full_unstemmed Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
title_short Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
title_sort transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676889/
https://www.ncbi.nlm.nih.gov/pubmed/26830688
http://dx.doi.org/10.1186/s12883-015-0515-x
work_keys_str_mv AT bergerbenjamin transientspuriousintrathecalimmunoglobulinsynthesisinneurologicalpatientsaftertherapeuticapheresis
AT hottenrotttilman transientspuriousintrathecalimmunoglobulinsynthesisinneurologicalpatientsaftertherapeuticapheresis
AT leubnerjonas transientspuriousintrathecalimmunoglobulinsynthesisinneurologicalpatientsaftertherapeuticapheresis
AT derschrick transientspuriousintrathecalimmunoglobulinsynthesisinneurologicalpatientsaftertherapeuticapheresis
AT rauersebastian transientspuriousintrathecalimmunoglobulinsynthesisinneurologicalpatientsaftertherapeuticapheresis
AT sticholiver transientspuriousintrathecalimmunoglobulinsynthesisinneurologicalpatientsaftertherapeuticapheresis
AT prussharald transientspuriousintrathecalimmunoglobulinsynthesisinneurologicalpatientsaftertherapeuticapheresis